Literature DB >> 24924443

Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy.

T Toyama1, K Ohtomo1, Y Noda1, T Ueta1.   

Abstract

PURPOSE: To evaluate the possible causative role of central serous chorioretinopathy (CSC) in the development of exudative age-related macular degeneration (AMD).
METHODS: In a cross-sectional study at an institutional setting, 150 control subjects who had senile cataract or nasolacrimal duct stenosis and who were older than 50 years were enrolled. The background data for 89 patients with typical AMD (tAMD) and 138 patients with polypoidal choroidal vasculopathy (PCV) were used for comparison. Their medical records were taken for history of CSC, hypertension, systemic steroid use, and smoking. The fundus was also evaluated for signs of atrophic retinal pigment epithelial (RPE) tract and for focal photocoagulation scars in the macula.
RESULTS: After adjusting for age, gender, and history of hypertension, systemic steroid use, and smoking, history of CSC was significantly more frequent (P<0.0001) in patients with PCV (15 patients, 10.9%) compared with patients with tAMD (2 patients, 2.2%) or control subjects (0 patients). On fundoscopy, an atrophic RPE tract (seven patients) or a focal photocoagulation scar (one patient) was observed only in patients with PCV (eight patients, 5.8%), and the frequency was statistically significant compared with that with tAMD (P=0.0143) or control subjects (P=0.0143). The laterality of CSC and AMD involved the same eye in 9 of 10 patients among those who had unilateral AMD and a reported unilateral CSC history.
CONCLUSION: A history of CSC may be a predisposing factor for the development of PCV in the Japanese population.

Entities:  

Mesh:

Year:  2014        PMID: 24924443      PMCID: PMC4135256          DOI: 10.1038/eye.2014.132

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  28 in total

1.  Long-term follow-up of idiopathic central serous chorioretinopathy without laser.

Authors:  D Bujarborua
Journal:  Acta Ophthalmol Scand       Date:  2001-08

2.  Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy.

Authors:  Roy H Loo; Ingrid U Scott; Harry W Flynn; J Donald M Gass; Timothy G Murray; Mary Lou Lewis; Phillip J Rosenfeld; William E Smiddy
Journal:  Retina       Date:  2002-02       Impact factor: 4.256

3.  Polypoidal choroidal vasculopathy and central serous chorioretinopathy.

Authors:  R M Ahuja; S M Downes; P E Stanga; A H Koh; J R Vingerling; A C Bird
Journal:  Ophthalmology       Date:  2001-06       Impact factor: 12.079

4.  Ocular perfusion pressure and choroidal thickness in eyes with polypoidal choroidal vasculopathy, wet-age-related macular degeneration, and normals.

Authors:  P Rishi; E Rishi; G Mathur; V Raval
Journal:  Eye (Lond)       Date:  2013-06-14       Impact factor: 3.775

5.  Polypoidal choroidal vasculopathy: natural history.

Authors:  Masanobu Uyama; Mitsumasa Wada; Yoshimi Nagai; Takashi Matsubara; Hiroshi Matsunaga; Ichiro Fukushima; Kanji Takahashi; Miyo Matsumura
Journal:  Am J Ophthalmol       Date:  2002-05       Impact factor: 5.258

6.  Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration.

Authors:  L A Yannuzzi; D W Wong; B S Sforzolini; M Goldbaum; K C Tang; R F Spaide; K B Freund; J S Slakter; D R Guyer; J A Sorenson; Y Fisher; D Maberley; D A Orlock
Journal:  Arch Ophthalmol       Date:  1999-11

7.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

8.  Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy.

Authors:  L A Yannuzzi; K B Freund; M Goldbaum; B Scassellati-Sforzolini; D R Guyer; R F Spaide; D Maberley; D W Wong; J S Slakter; J A Sorenson; Y L Fisher; D A Orlock
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

9.  Choroidal capillary and venous congestion in central serous chorioretinopathy.

Authors:  C Prünte; J Flammer
Journal:  Am J Ophthalmol       Date:  1996-01       Impact factor: 5.258

10.  Risk factors for central serous chorioretinopathy: a case-control study.

Authors:  Robert Haimovici; Sean Koh; David R Gagnon; Todd Lehrfeld; Sarah Wellik
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

View more
  8 in total

1.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 2.  A new insight into pachychoroid diseases: Remodeling of choroidal vasculature.

Authors:  Shoji Kishi; Hidetaka Matsumoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-16       Impact factor: 3.535

3.  Type 1 neovascularization with polypoidal lesions complicating dome shaped macula.

Authors:  Jonathan Naysan; Kunal K Dansingani; Chandrakumar Balaratnasingam; K Bailey Freund
Journal:  Int J Retina Vitreous       Date:  2015-07-09

4.  CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy.

Authors:  Yoshikatsu Hosoda; Munemitsu Yoshikawa; Masahiro Miyake; Yasuharu Tabara; Jeeyun Ahn; Se Joon Woo; Shigeru Honda; Yoichi Sakurada; Chieko Shiragami; Hideo Nakanishi; Akio Oishi; Sotaro Ooto; Akiko Miki; Tomohiro Iida; Hiroyuki Iijima; Makoto Nakamura; Chiea Chuen Khor; Tien Yin Wong; Kyuyoung Song; Kyu Hyung Park; Ryo Yamada; Fumihiko Matsuda; Akitaka Tsujikawa; Kenji Yamashiro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

Review 5.  Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds.

Authors:  Kenji Yamashiro; Yoshikatsu Hosoda; Masahiro Miyake; Sotaro Ooto; Akitaka Tsujikawa
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

6.  Remodeling of macular vortex veins in pachychoroid neovasculopathy.

Authors:  Hidetaka Matsumoto; Shoji Kishi; Ryo Mukai; Hideo Akiyama
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

7.  Optical Coherence Tomography Angiography in Central Serous Chorioretinopathy.

Authors:  Eliana Costanzo; Salomon Yves Cohen; Alexandra Miere; Giuseppe Querques; Vittorio Capuano; Oudy Semoun; Ala'a El Ameen; Hassiba Oubraham; Eric H Souied
Journal:  J Ophthalmol       Date:  2015-11-08       Impact factor: 1.909

8.  Pachychoroid neovasculopathy and age-related macular degeneration.

Authors:  Masahiro Miyake; Sotaro Ooto; Kenji Yamashiro; Ayako Takahashi; Munemitsu Yoshikawa; Yumiko Akagi-Kurashige; Naoko Ueda-Arakawa; Akio Oishi; Hideo Nakanishi; Hiroshi Tamura; Akitaka Tsujikawa; Nagahisa Yoshimura
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.